NCT01299857View on ClinicalTrials.gov

Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab

PHASE3CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2012

Conditions
Pemphigus
Interventions
DRUG

Rituximab

375mg/m2

Trial Locations (1)

Unknown

UH-Rouen, Rouen

All Listed Sponsors
lead

University Hospital, Rouen

OTHER

NCT01299857 - Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by Rituximab | Biotech Hunter | Biotech Hunter